5th Circ. Quashes Generic Reglan Failure-To-Warn Suit
The Fifth Circuit refused Wednesday to resurrect failure-to-warn claims against three generic-drug makers, ruling that the companies had no duty to issue a warning about health risks linked to the anti-nausea...To view the full article, register now.
Already a subscriber? Click here to view full article